OpenResearchAlpha

bioRxiv · 18 Nov 2026

CD38-NAMPT-p21 signaling promotes stress adaptation in CLL

BING HANh-index 3, Claudia CS Chini, GINA CICCIO LOPEZ, YUKI HAMADA, ANEEL PAULUS, ASHER CHANAN-KHAN, ESTEBAN BRAGGIO, ANDERS BERGLUND, Eduardo Nunes Chini

0
Citations
no database records one yet
0
Citations in 2026
so far
3
Leading author's h-index
BING HAN, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the United States, accounting for ~30% of new diagnoses and ~4,000 deaths annually. High CD38 expression is a well-established marker of poor prognosis, yet the mechanistic basis of CD38-mediated treatment failure has remained incompletely understood. Here, we demonstrate that CD38 functions not merely as a prognostic biomarker but as a metabolic and signaling regulator that equips CLL cells to withstand cytotoxic and hypoxic stress. Using MEC-1 cells engineered to express CD38, we identified a CD38-NAMPT-p21 survival axis that confers resistance to fludarabine and hypoxia. CD38 NADase activity promoted NAMPT upregulation and AKT activation and was associated with accumulation of cytoplasmic p21. This CD38-dependent phenotype was lost in cells expressing a catalytically inactive CD38 mutant and was also reversed by pharmacologic inhibition of NAMPT (FK866) or suppression of p21 (UC2288). Analysis of three independent single-cell RNA-sequencing datasets of primary CLL further showed that naturally occurring CD38-positive CLL cells exhibit increased NAMPT expression and related stress-response signaling. Analysis of larger primary CLL cohorts further linked NAMPT expression to AKT and hypoxia signatures, providing additional support for the relevance of this pathway in patient-derived CLL. Together, these findings identify CD38-NAMPT-p21 signaling as an important mechanism of stress adaptation in CLL and suggest that targeting NAD⁺ metabolism and p21-mediated survival pathways may represent a potential strategy for CD38-high disease.

Cancer biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • BING HAN has the highest h-index among the authors (3).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (9)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.